{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:05:15Z","timestamp":1774551915317,"version":"3.50.1"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,10]]},"DOI":"10.18632\/oncotarget.8487","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T23:50:41Z","timestamp":1459381841000},"page":"27552-27566","source":"Crossref","is-referenced-by-count":6,"title":["Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Bihui","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan, USA"},{"name":"Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Yin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Products and Jiangsu Key Laboratory of Traditional Chinese Medicine (TCM) Evaluation and Translational Research, Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, China"},{"name":"Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"Yale Stem Cell Center, Yale University, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Cao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Products and Jiangsu Key Laboratory of Traditional Chinese Medicine (TCM) Evaluation and Translational Research, Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Qi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Products and Jiangsu Key Laboratory of Traditional Chinese Medicine (TCM) Evaluation and Translational Research, Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Harbin Medical University, Harbin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wayne State University, Detroit, Michigan, USA"},{"name":"Tumor Biology and Microenvironment Program, Barbara Ann Karmanos Cancer Center and Department of Oncology, Wayne State University, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junping","family":"Kou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Products and Jiangsu Key Laboratory of Traditional Chinese Medicine (TCM) Evaluation and Translational Research, Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan, USA"},{"name":"Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Detroit, Michigan, USA"},{"name":"Tumor Biology and Microenvironment Program, Barbara Ann Karmanos Cancer Center and Department of Oncology, Wayne State University, Detroit, Michigan, USA"},{"name":"Department of Immunology and Microbiology, Wayne State University, Detroit, Michigan, USA"},{"name":"Mucosal Immunology Studies Team, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyang","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Products and Jiangsu Key Laboratory of Traditional Chinese Medicine (TCM) Evaluation and Translational Research, Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Thun","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.02.044","article-title":"Prevalence of cysts in epithelial ovarian cancer","volume":"151","author":"Massuger","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1525-1438.2007.00824.x","article-title":"Ovarian cancer incidence and survival in Korea: 1993-2002","volume":"17","author":"Lee","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.25689","article-title":"LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis","volume":"129","author":"Zhou","year":"2011","journal-title":"Int J Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","article-title":"Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data","volume":"377","author":"Adolfsson","year":"2011","journal-title":"Lancet"},{"key":"6","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/pr070041v","article-title":"Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers","volume":"6","author":"Muddiman","year":"2007","journal-title":"J Proteome Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jso.21912","article-title":"Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer","volume":"104","author":"Zhou","year":"2011","journal-title":"J Surg Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Coukos","year":"2011","journal-title":"Nature"},{"key":"9","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/1078-0432.CCR-14-2279","article-title":"Rac1\/Pak1\/p38\/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer","volume":"21","author":"Calin","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.yexcr.2003.09.016","article-title":"HGF and ligation of alphavbeta5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering","volume":"292","author":"Lindsey","year":"2004","journal-title":"Exp Cell Res"},{"key":"11","first-page":"37","article-title":"Carcinoma cell-specific Mig-7: a new potential marker for circulating and migrating cancer cells","volume":"13","author":"Lindsey","year":"2005","journal-title":"Oncol Rep"},{"key":"12","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/1535-7163.MCT-09-0186","article-title":"Targeting migration inducting gene-7 inhibits carcinoma cell invasion, early primary tumor growth, and stimulates monocyte oncolytic activity","volume":"8","author":"Lindsey","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1158\/0008-5472.CAN-12-2220","article-title":"MIG-7 controls COX-2\/PGE2-mediated lung cancer metastasis","volume":"73","author":"Liang","year":"2013","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2353\/ajpath.2007.060969","article-title":"Overexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formation","volume":"170","author":"Lindsey","year":"2007","journal-title":"Am J Pathol"},{"key":"15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Gerdes","year":"2000","journal-title":"J Cell Physiol"},{"key":"16","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","author":"Amedei","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"17","first-page":"569","article-title":"[Modernization of Chinese Materia Medica and I]","volume":"22","author":"Xiao","year":"2002","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1158\/1535-7163.MCT-05-0520","article-title":"RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor","volume":"5","author":"Nargi","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"19","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood-2011-03-341214","article-title":"Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice","volume":"118","author":"Hajjar","year":"2011","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"21","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"van Bree","year":"2006","journal-title":"Nat Protoc"},{"key":"22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1073\/pnas.92.3.768","article-title":"Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis","volume":"92","author":"Keshet","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.18632\/oncotarget.2804","article-title":"MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion\/metastasis","volume":"6","author":"Liang","year":"2015","journal-title":"Oncotarget"},{"key":"24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10456-005-9001-1","article-title":"Angiogenesis in normal and neoplastic ovaries","volume":"8","author":"Geller","year":"2005","journal-title":"Angiogenesis"},{"key":"25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ncponc1051","article-title":"Angiogenesis as a strategic target for ovarian cancer therapy","volume":"5","author":"Coleman","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.humpath.2014.06.013","article-title":"Vasculogenic mimicry: a new prognostic sign of human osteosarcoma","volume":"45","author":"Sun","year":"2014","journal-title":"Hum Pathol"},{"key":"27","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2007.11.5345","article-title":"Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Sorosky","year":"2007","journal-title":"J Clin Oncol"},{"key":"28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2006.05.006","article-title":"Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer","volume":"102","author":"Burger","year":"2006","journal-title":"Gynecol Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3747\/co.2007.132","article-title":"Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND. 182-185","volume":"14","author":"Eisenhauer","year":"2007","journal-title":"Curr Oncol"},{"key":"30","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1200\/JCO.2009.23.2777","article-title":"Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer","volume":"27","author":"Sullivan","year":"2009","journal-title":"J Clin Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1200\/JCO.2010.34.3178","article-title":"Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer","volume":"30","author":"Stepan","year":"2012","journal-title":"J Clin Oncol"},{"key":"32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6604767","article-title":"Antiangiogenic drugs in ovarian cancer","volume":"100","author":"Clamp","year":"2009","journal-title":"Br J Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1158\/0008-5472.CAN-06-3608","article-title":"Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells","volume":"67","author":"Ramakrishnan","year":"2007","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)64505-1","article-title":"Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma","volume":"161","author":"Coukos","year":"2002","journal-title":"Am J Pathol"},{"key":"35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bjc.6604921","article-title":"The VEGF pathway and the AKT\/mTOR\/p70S6K1 signalling pathway in human epithelial ovarian cancer","volume":"100","author":"van Dam","year":"2009","journal-title":"Br J Cancer"},{"key":"36","first-page":"5224","article-title":"Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation","volume":"63","author":"Giavazzi","year":"2003","journal-title":"Cancer Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"200s","DOI":"10.1200\/JCO.2003.01.068","article-title":"Status of tumor markers in ovarian cancer screening","volume":"21","author":"Bast","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:51:17Z","timestamp":1589226677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":37,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016,5,10]]}},"alternative-id":["8487","27050277"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8487","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]}}}